The HIV-1 encoded accessory protein, viral protein R (Vpr) is responsible for several biological effects in HIV-1-infected cells including nuclear transport of the preintegration complex, activation of long terminal repeat (LTR)-mediated transcription, and the induction of cell-cycle arrest and apoptosis. Vpr's ability to arrest cells at the G2 phase of the cell cycle is due to the inactivation of p34 cdc2 cyclin B complex, resulting in hypophosphorylation of substrates involved in cell-cycle progression from G2 to mitosis (M). Poly(A) polymerase (PAP), the enzyme responsible for poly(A) addition to primary transcripts, contains multiple consensus phosphorylation sites for p34 cdc2 cyclin B kinase that regulates its catalytic activity. We investigated the effects of Vpr on the activity of PAP in Jurkat cells using a superinfection system. Superinfection of cells using Vprϩ vesicular stomatitis virus G protein (VSV-G)-pseudotyped virus caused a complete dephosphorylation of PAP. Cotransfection studies in 293T cells and Xenopus oocyte RNA injection experiments mirrored these effects. Vpr's dramatic effect on PAP dephosphorylation was reflected in enhanced polyadenylation activity in PAP activity assays. HIV-1 Vpr appears to enhance processes that are coupled to transcription such as polyadenylation and could ultimately prove to optimize HIV-1 replication and contribute to HIV-1 pathogenesis. © 2002 Elsevier Science
INTRODUCTION
The HIV-1 encoded accessory protein, viral protein R (Vpr), is incorporated into viral particles, suggesting that it has functional importance early in infection. Indeed, Vpr functions early in infection to induce G2 cell-cycle arrest and mediate the nuclear import of the HIV-1 preintegration complex (Emerman, 1996; Mahalingam et al., 1998; Planelles et al., 1996; Poon et al., 1998; Re and Luban, 1997; Stewart et al., 1997; Stivahtis et al., 1997) . In addition, several other biological roles for Vpr have been described and these include the activation of long-terminal repeat (LTR)-mediated transcription (Agostini et al., 1996; Yao et al., 1998) , the induction of apoptosis (Conti et al., 2000 (Conti et al., , 1998 , and an implication in reverse transcriptase fidelity (Mansky, 1996) . Recent evidence also suggests that Vpr may perturb RNA metabolism by blocking RNA export as shown in yeast (Gu et al., 1997; Vodicka et al., 1998) . The mechanisms by which Vpr mediates these latter functions remain to be fully characterized, however. Vpr is not essential for HIV-1 replication in tissue culture systems; nevertheless, these Vpr effects appear to con-tribute significantly to the enhancement of HIV-1 pathogenesis (Cullen, 1998; Emerman and Malim, 1998; Subbramanian and Cohen, 1994) .
Vpr's ability to cell-cycle arrest at the G2 phase of the cell cycle is mediated by the inactivation of a cyclindependent kinase, p34 cdc2 cyclin B complex, resulting in hypophosphorylation of substrates involved in cell-cycle progression from G2 to mitosis (M). Arrest at the G2 phase has been shown to enhance LTR-driven transcription, suggesting that Vpr creates an environment in which viral gene transcription is favored (Goh et al., 1998; Hrimech et al., 1999) . We and others (Gozlan et al., 1998) have shown that the enhancement of HIV-1 transcription is modest, reaching about fivefold in experimental settings. This enhancement may be enough to sustain a replicative advantage in host cells, but also may require the action of Tat or other factors to sustain it .
Poly(A) polymerase (PAP) is the enzyme primarily responsible for poly(A) addition to primary transcripts in the nucleus. In the carboxyl-terminus, PAP contains multiple consensus and nonconsensus phosphorylation sites for p34 cdc2 cyclin B kinase and is a substrate for this and other kinases (Bond et al., 2000; Colgan et al., 1996 Colgan et al., , 1998 . The phosphorylation status of PAP modulates its activity with the nonphosphorylated protein being the most active (Colgan et al., 1998) . While it is clear that completely phosphorylated PAP has negligible poly(A) addition activity, functional differences between differentially phosphorylated forms of PAP are not so clear-cut (Bond et al., 2000) . There is a gradient of PAP phosphorylated species indicating that the extent to which each is phosphorylated may determine function within the cell (Kyriakopoulou et al., 2001; Zhao and Manley, 1998 ) and during the cell cycle (Bond et al., 2000) . Hyperphosphorylation of p34 cdc2 cyclin B kinase is a consequence of cell-cycle progression to M phase resulting in PAP hyperphosphorylation and is coincident with a suppression of protein and RNA synthesis during cell division (Bonneau and Sonenberg, 1987; Colgan et al., 1996 Colgan et al., , 1998 .
We investigated the influence of Vpr on the activity of PAP in superinfected Jurkat cells using VSV-G pseudotyped HIV-1 virus. Superinfection of cells using VprϪ and Vprϩ virus demonstrated a specific effect of Vpr on nuclear and whole-cell PAP phosphorylation status. Remarkably, we observed a complete dephosphorylation of PAP due to the expression of Vpr early postinfection. Cotransfection studies in 293T cells and coinjection experiments using Xenopus oocytes mirrored these effects on PAP phosphorylation status. Results from polyadenylation activity assays demonstrated increased PAP activity in fractionated infected cells due to Vpr. In vitro studies explored the result of PAP dephosphorylation on HIV-1 RNA metabolism and poly(A) tail length. Whereas PAP activity was enhanced, neither the 3Ј poly(A) tail length nor the mRNA half-life was markedly altered. Vpr not only appears to have a direct transactivation function, but can have downstream effects on closely coupled gene regulation steps involving 3Ј-end processing, a step that is now appreciated to be tightly coupled to transcription (Calvo and Manley, 2001; Dantonel et al., 1997; Hirose and Manley, 1998; McCracken et al., 1997; Zhao et al., 1996) . Figure 1A shows the phosphorylation status of PAP in nuclear extracts from mock control, VprϪ, Vprϩ, and R80A Vpr VSV-G-pseudotyped virus-infected Jurkat cells. In both Jurkat and HeLa (not shown) cells, two to three PAP isoforms were observed ranging in molecular weight from 97 to 105 kDa. Higher molecular weight forms represent the phosphorylated species (PPAP). The dephosphorylated form of PAP is known to be catalytically active, as phosphorylation negatively affects activity (Colgan et al., 1998) . In VprϪ, R80A Vpr, and mock virus-infected cells, PAP is found as several bands on SDS gels, demonstrating that a distribution of PAP activity is found in these cells . In Vprϩ virusinfected cells, however, the predominant PAP is in a completely hypophosphorylated state, suggesting a spe-cific effect of HIV-1 Vpr on PAP phosphorylation. Since p34 cdc2 kinase activity is negatively affected by Vpr, and PAP is a substrate for p34 cdc2 kinase on multiple consensus and nonconsensus sites, this result was not entirely surprising. However, the dramatic difference in phosphorylation status of PAP mediated by Vpr in infected cell preparations was not at all expected. The R80A Vpr mutant, a mutant that does not cause cell-cycle arrest , generated a PAP phosphorylation status identical to that in mock-and VprϪ virus-infected cells. A timecourse experiment was performed on whole-cell extracts (Fig. 1B ). As early as 6 h p.i. PAP is dephosphorylated via virion-associated Vpr. As a control for PAP phosphorylation, nocodazole was used to cause M phase arrest in which PAP becomes completely hyperphosphorylated as described before (Figs. 1B and 1C) (Colgan et al., 1996; Hirose and Manley, 1998) . Thus, the cell-cycle arrest phenotype by Vpr correlates well with G2 arrest. Using whole-cell extracts, we routinely observed one principal PAP band, while two to three PAP-specific bands were observed in blots using nuclear extracts. The reasons for this difference are unclear but could reflect the extraction method used.
RESULTS

Vpr-mediated hypophosphorylation of poly(A) polymerase
Apoptosis was assessed by Annexin V staining; this was only apparent in superinfected Vprϩ and becomes apparent only after 20 h (data not shown; Yao et al., 1998) .
To determine whether the effects of Vpr on PAP phosphorylation could be observed during transient expression, Vpr was coexpressed with PAP using EukPAP and SVCMV-Vpr expression plasmids in 293T cells (Figs. 2A and 2B) followed by metabolic labeling. PAP expression alone yielded a single immunoreactive band at approxi-mately 100 kDa, while coexpression of Vpr and PAP in 293T cells caused the appearance of a lower apparent molecular weight PAP consistent with dephosphorylation of a portion of endogenous and overexpressed PAP ( Fig.  2A ). The proportion of PAP in a dephosphorylated state was not as marked as that presented in Fig. 1 likely because the efficiency of transfection was markedly reduced compared to the superinfection efficiency that was routinely 95-100%. Figure 2B shows the level of expression of Vpr in EukPAP and SVCMV-Vpr-transfected cells.
The Vpr-induced PAP dephosphorylation was also tested in RNA injection experiments using Xenopus laevis oocytes to further substantiate Vpr's effect on PAP phosphorylation. In Xenopus oocytes, injected PAP RNA yields a 97-kDa band. When PAP RNA is injected into oocytes that are induced to mature with progesterone, PAP become hyperphosphorylated ( Fig. 2C ). When both PAP and Vpr RNAs are coinjected, and then induced to mature with progesterone, Vpr expression prevented the maturation-induced hyperphosphorylation of PAP ( Fig.  2C ). This indicates that Vpr can modulate a specific phosphorylation activity or phosphatase activity on PAP protein. Figure 2D demonstrates the expression levels of Vpr in injected oocytes.
Vpr modestly enhances steady-state HIV-1 RNA levels without a concomitant effect on RNA stability
Because PAP activity was dramatically enhanced in Vprϩ-infected cells, we reasoned that the poly(A) tail length of HIV-1 mRNAs could be increased accordingly and as a result HIV-1 RNA stability be increased. mRNA stability measurements were performed using the transcription inhibitor, Actinomycin D. Figure 3 shows the results of the mRNA stability estimations at 20 h p.i. This represents the time at which cell-cycle analysis was performed and nuclear and whole-cell extracts were prepared (cf. Figs. 1 and 2) . At 20 h p.i. (time 0 in Fig. 3) , we observed the expected modest stimulation of steadystate HIV-1 mRNA levels as we have shown previously . The RNA half-lives were determined for the unspliced, singly spliced, and multiply spliced HIV-1 mRNA species and these were found to be approximately equivalent, of about 5-6 h (bottom panel) in both VprϪ and Vprϩ-superinfected cells. Cellular GAPDH, whose mRNA half-life is greater than 24 h (Mouland and Hendy, 1991) , was used to control for RNA loading. We did observe, however, that when the signal intensities for each size class of HIV-1 mRNA was compared at time 0, Vpr expression slightly altered the ratio of unspliced to spliced RNA species (see histogram insets).
Vpr has no effects on HIV-1 poly(A) tail lengths
Since there were no apparent changes in HIV-1 mRNA stability, which is anyhow not always accompa- (C) Xenopus laevis oocytes were injected with water (mock), PAP RNA, Vpr RNA, or coinjected with Vpr and PAP RNAs. PAP RNA-injected oocytes were left untreated (Ϫ) or induced to mature by the addition of progesterone (ϩ). Oocytes were processed as described under Materials and Methods and PAP and Vpr were sequentially immunoprecipitated from oocyte lysates. Progesterone treatment induced PAP phosphorylation (PPAP); however, when Vpr was coexpressed (PAPϩVpr RNA) and subsequently induced to mature with progesterone, PAP phosphorylation was blocked. Vpr expression in oocytes was confirmed on the right. The results shown are representative of two to three experiments. nied with increased poly(A) tail lengths (Richter, 1996) , examination of the length of the poly(A) tail of HIV-1 transcripts was warranted. An RNAseH assay was used to estimate poly(A) tail length of all HIV-1 transcripts with the use of an antisense DNA oligomer to a common region of HIV-1 transcripts. Cytosolic RNA was isolated from superinfected cells at 20 h p.i. and incubated with an antisense oligomer to the 3Ј-UTR region of HIV-1 mRNAs as described under Materials and Methods. Following digestion with RNAseH, the protected fragment was separated on a denaturing agarose gel followed by blotting onto nitrocellulose membranes. Probing of the RNA with a 32 P-labeled DNA to the Gag leader sequence revealed that the poly(A) tail length of HIV-1 RNAs was not affected when Vpr was expressed, and this was found to be approximately 250 bp long (Fig. 4) . The modest enhancement of Vpr-induced steady-state levels of RNA were observed as before ( Fig. 3 and Yao et al., 1998) . Actin and GAPDH poly(A) tail lengths were also determined in this assay and remained unchanged with Vpr treatment (data not shown).
FIG. 3. Vpr modestly enhances steady-state HIV-1 RNA levels, but does not affect mRNA stability. Jurkat cells were superinfected with Vprϩ or VprϪ virus as described under Materials and Methods to result in 95-98% infection. Twenty hours postinfection, cells were washed and treated with Actinomycin D (Act D). At 0, 3, and 6 h after treatment, cytosolic RNA was prepared. (A) RNAs were loaded onto 1% agarose/formaldehyde gels, transferred to nylon, and probed with a 32 P-labeled 285-bp probe to the 5ЈUTR of HIV-1 RNA to detect unspliced (9 kb) and unspliced (4 and 2 kb) HIV-1 RNAs. The blot was subsequently probed for GAPDH mRNA. 28S and 18S rRNAs were revealed by ultraviolet transillumination. Each species of HIV-1 RNA was quantitated by laser scanning densitometry and related to the signal obtained with GAPDH mRNA at each time point. The relative signal intensities were plotted versus time, with HIV-1 RNA at time 0 set to 100%. Histogram insets indicate fold induction of the signal intensity caused by Vpr of each RNA species at time 0. No marked effects of Vpr on mRNA stability were observed. The results shown are representative of two experiments.
Hypophosphorylation of poly(A) polymerase in Vprϩinfected cells is reflected in an increase in polyadenylation activity iv vitro
We then measured the poly(A) addition activity in vitro using purified PAP from superinfected Jurkat cells (mock, VprϪ, Vprϩ, and R80A Vpr) in a nonspecific poly(A) assay. Data in Fig. 5 demonstrate that there is an enhancement of adenosine triphosphate addition in Vprϩ-infected cells. The effect on poly(A) activity using extracts from VprϪ virus was identical to that of the R80A Vpr (data not shown). To rule out differences in PAP activity between gel elution fractions (see Materials and Methods), aliquots from fractions surrounding the peak eluate were included in the assay. In each case all the fractions from a given condition showed similar phenomena, i.e., nonpeak eluates from Vprϩ-infected cells showed enhanced PAP activity than mock or Vpr Ϫ virus (data not shown).
DISCUSSION
In this study we have provided evidence that PAP activity in HIV-1 infected cells is modulated by the HIV-1 auxiliary protein, Vpr. PAP is shown here to become almost completely dephosphorylated when HIV-1 Vpr is expressed by using whole-cell and nuclear extracts, transient transfections, and in vivo metabolic labeling. In injected Xenopus oocytes, Vpr also blocks the maturation-specific phosphorylation of PAP in progesteroneinduced Xenopus oocytes. PAP dephosphorylation is likely to be initiated by the immediate-early effects of Vpr , mediated at least in part by the virion-associated Vpr since PAP dephosphorylation is observed as early as 6 h postinfection (Fig. 1B) , before de novo synthesis of viral proteins (Reddy and Yin, 1999) . Moreover, because PAP phosphorylation is only affected in late M phase of the cell cycle (J. Manley, Columbia University, personal communication), the effects on PAP phosphorylation status could not be a consequence of a Vpr-mediated G2 arrest. While Vpr modulates p34 cdc2 kinase activity and PAP is a substrate for this kinase, the magnitude of PAP dephosphorylation due to Vpr was completely unexpected. In Fig. 1 , we identify at least three major PAP isoforms in nuclear extracts. Vpr causes a complete loss of the two phosphorylated, higher molecular weight species (Fig. 1A) (Thuresson et al., 1994) . PAP contains multiple cdk consensus and nonconsensus sites in the carboxyl-terminal region (Colgan et al., 1996 (Colgan et al., , 1998 . While it is clear that cyclins A and B kinases can phosphorylate several of these sites, other kinases are also believed to be involved . As is the case for SR proteins during splicing (Cao et al., 1997; Gui et al., 1994; Xiao and Manley, 1997) , phosphorylation of PAP will likely prove to be critical for function. However, a complete picture of the importance of each of the PAP species remains to be drawn.
Phosphorylation is central to many biological processes including transcription, splicing, nucleocytoplasmic transport, and translation. For PAP, phosphorylation has been shown to be critical by several measures. Phosphorylation levels determine PAP's activity during the cell cycle (Colgan et al., 1996 (Colgan et al., , 1998 and the localization of the active (dephosphorylated) form of PAP is localized to specific regions of active RNA synthesis within the nucleus (Schul et al., 1998) . Furthermore, a phosphorylation mutant of PAP was recently shown to be highly deleterious to cell growth . More recent data provide evidence that PAP's interactions with cyclins modulate PAP phosphorylation (Bond et al., 2000) , indicating that protein interactions with cyclins are important for function. The carboxyterminal region of PAP is responsible for several interactions that control polyadenylation activity (Gunderson et al., 1998 (Gunderson et al., , 1997 . It will be interesting to assess if HIV-1 Vpr can upset PAP's interactions, thereby preventing PAP phosphorylation in HIV-1-infected cells.
When PAP activity was tested in vitro in nuclear extracts, a dramatic increase in poly(A) addition activity was observed (Fig. 5 ). We then examined potential consequences of this enhanced PAP activity due to PAP dephosphorylation, but this was not reflected in differences in HIV-1 RNA poly(A) tail length (Fig. 4) nor did it produce HIV-1 transcripts with altered stability (Fig. 3) . In light of Vpr's transactivation function , its capacity to bind basal transcription factors such as TFIIB and p300 (Agostini et al., 1996; Felzien et al., 1998) and to mediate G2 arrest in infected cells, we tested the effects of overexpressing PAP on Vpr transactivation and G2 arrest in transient transfection studies but these studies did not reveal anything about the influence of PAP activity at these levels (not shown).
Polyadenylation requires an ordered assembly of components that includes poly(A)-binding protein (PABP), cleavage/polyadenylation specificity factor (CPSF), and PAP on the RNA (Colgan and Manley, 1997) . Phosphorylation of proteins is known to influence both RNA and protein interactions (Idriss et al., 1994; Tacke et al., 1997; Xiao and Manley, 1997) . These types of associations are also critical to poly(A) tail elongation (Wahle, 1995) . It is possible that PAP dephosphorylation would favor the binding or the association between it and HIV-1 RNA, or with proteins involved in the polyadenylation process (Gilmartin et al., 1995; Murthy and Manley, 1995) . CPSF is known to bind PAP (Murthy and Manley, 1995) and this association might favor polyadenylation activity in the infected cell. Indeed, U1A-CPSF binding stabilizes CPSF binding on RNA substrates (Lutz et al., 1996) , and in HIV-1, cyclinT1-Tat binding positively influences HIV-1 TAR RNA binding (Ivanov et al., 1999; Wei et al., 1998) . As a result of these stabilized interactions, elongation of the poly(A) tail may be facilitated. Since we do not detect any change in HIV-1 RNA poly(A) tail length or RNA turnover, this model would dictate that polyadenylation is facilitated by Vpr due to its influence on PAP phosphorylation status. More refined studies to examine this possibility will be required.
PAP dephosphorylation is tightly coupled to the prevention of apoptosis in several cell types in which PAP dephosphorylation is an early event that precedes DNA fragmentation (Atabasides et al., 1998) . HIV-1 Vpr is involved in the prevention of apoptosis in HIV-1-infected cells (Ayyavoo et al., 1997; Conti et al., 1998; Stewart et al., 1997; Yao et al., 1998) . The low level of Vpr achieved early postinfection due to virion-associated Vpr is likely responsible for its antiapoptotic activity (Conti et al., 1998) . This would be consistent with recent findings that show that when Vpr is expressed to low levels, this activity is observed (Conti et al., 2000) . The similarity in function raises the intriguing possibility that the antiapoptotic activities of Vpr and PAP overlap in infected cells. Consistently, Vpr-mediated dephosphorylation of PAP appears to be an early event occurring as early as 6 h p.i. (Fig. 1B) , when apoptosis is not yet detectable (Fig. 1D at 20 h postinfection) and when de novo viral gene expression is not evident (Reddy and Yin, 1999) . Vpr's effect on PAP phosphorylation status may thus reflect the combined antiapoptotic activities of Vpr and PAP. This idea remains to be confirmed.
The rate limiting steps for export is 3Ј-end processing, including cleavage and poly(A) addition; at least this is the case for cellular RNAs (Custodio et al., 1999) . Furthermore, defects in mRNA export appear to cause hyperadenylation of de novo synthesized RNAs (Custodio et al., 1999; Hilleren and Parker, 2001) . Enhanced polyadenylation activity (Fig. 5 ) mediated by Vpr could conceivably mediate a block in cellular RNA export during HIV-1 replication. Consistently, Vpr has been shown to cause an mRNA export defect similar to that found when importin-␤ is overexpressed (Vodicka et al., 1998) . While polyadenylation is a prerequisite for HIV-1 Rev-mediated RNA nucleocytoplasmic transport (Huang and Carmichael, 1996) and 3Ј-end processing is necessary for nuclear export (Custodio et al., 1999; Eckner et al., 1991) , the data in this study could be suggestive of a model in which Vpr induces hyperactivity of PAP to favor a cellular RNA block in the nucleus due to hyperadenylation. Since HIV-1 RNA poly(A) tails remain unchanged, this indicates that HIV-1 RNA is not affected by PAP hyperactivity and this could provide for a replicative advantage for the virus to export its RNAs from the nucleus. The future identification of specific cellular hyperadenylated mRNAs that are sequestered in the nuclear compartment would support this hypothesis.
The novelty of this article is the elucidation of the involvement of the RNA processing enzyme PAP as a downstream effector of Vpr. Whatever the relationship may be between PAP dephosphorylation and HIV-1 infection, the implication of Vpr in this alludes to a functional role in cell-cycle control, apoptosis, and/or gene expression.
MATERIALS AND METHODS
Superinfection
Vesicular stomatitis virus G protein-pseudotyped HIV-1 particles were generated in 293T cells as described before . A Vprϩ, VprϪ, and a R80A Vpr mutant were included in these analyses. The description of these clones is described in Yao et al. (1998) . Jurkat cells were infected in 100 L RPMI medium ϩ 10% fetal calf serum (FCS) at a multiplicity of infection of 10 for 4 h, followed by extensive washing and resuspension in fresh culture medium. At 0, 6, 12, or 20 h p.i., cells were washed extensively in ice-cold PBS and nuclear and/or cellular extracts were prepared as described below. All experiments were performed in both Jurkat T and HeLa cells. Data from Jurkat cells are shown.
DNAs
A mammalian PAP expressor was generated in the following way. A bacterial expression plasmid, pGM10-His6/BPAP82KCR, was generously supplied by Drs. Georges Martin and Walter Keller (Biozentrum of Basel University, Switzerland). Since this vector is optimized for prokaryotic expression, the initiation codon was modified to fit the Kozak eukaryotic consensus sequence (Kozak, 1984) using the oligomer, 5Ј-gcacttagacgATGccgtttccagttacaa. A 930-bp (XbaI/KpnI) fragment was amplified and was used to replace the corresponding region in pGM10-His6/BPAP82KCR to generate EukPAP. A 2230-bp XbaI/BamHI fragment was placed into pCEP (Novagen) and used for constitutive expression from the cytomegalovirus early promoter in transiently transfected 293T cells.
The same fragment was used to generate the transcription vector, KSPAPpoly(A)ϩ; a 2230-bp XbaI/BamHI fragment was placed into KSII (Stratagene), and a SacI/ HindIII fragment from sp64poly(A)ϩ vector (Promega) that contains a 30-nucleotide poly(A) tail was inserted downstream to generate KSPAPpoly(A)ϩ.
Vpr was placed into pET-21c (Novagen) in-frame with a T7 tag as described and the poly(A) SacI/HindIII fragment was inserted downstream of Vpr in pET-21c to generate pET-21cVprPoly(A)ϩ. For Vpr and PAP RNA synthesis, in vitro transcription was performed in the presence of the cap analogue to prepare polyadenylated, capped RNAs for oocyte injections described below.
Transient transfections
293T cells were cultured in DMEM with 10% FCS and antibiotics. Calcium phosphate coprecipitation was used for transfections. The wild-type CMV-Vpr expressor used here was described previously . At 36 h, cells were pulsed with 300 Ci 35 S-TransLabel (ICN) for 12 h. Cells were then lysed in RIPA buffer (0.15 M NaCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 0.01% SDS, 0.2% NP-40, 0.05% sodium deoxycholate) and sequentially immunoprecipitated with 2 L anti-PAP (Colgan et al., 1996) , and anti-Vpr. For mock lanes, 293T cells were transfected with either EukPAP or SVCMV-Vpr followed by immunoprecipitation with preimmune rabbit serum. Immunoprecipitates were run on SDS-PAGE gels (7% for PAP and 12% for Vpr), dried, and exposed to film.
Cell-cycle and Annexin V apoptosis analyses were performed at 20 h postinfection as described previously .
Oocyte injections
Stage 6 oocytes were harvested as described (Coady et al., 1998) and injected with 500 ng PAP, Vpr, or both PAP and Vpr RNA (polyadenylated and capped as described above), or water as control. Oocytes were maintained in Barth's [90 mM NaCl, 3 mM KCl, 0.82 mM MgSO 4 , 0.41 mM CaCl 2 , 0.33 mM Ca(NO 3 ) 2 , 5 mM HEPES, pH 7.6]. At 12 h, the oocytes were induced to mature with the use of 25 M progesterone (Sigma). At 36 h, oocytes were harvested in phosphate-buffered saline and homogenized using an Eppendorf pestle. Lipids and membranes were removed by extraction with 1, 1,2trichlorotrifluorethane. RIPA (400 L) was added to the lysate, and PAP and Vpr were immunoprecipitated as described above. The oocyte injection experiments have been optimized to allow for maximal Vpr expression at the time of homogenization (36-44 h postinjection; A. J. Mouland and M. Coady, unpublished observations) .
Nuclear and whole-cell extracts
Nuclear extracts were prepared from 100-150 ϫ 10 6 cells for each infection by a modified nuclear extract lysolecithin method (Zerivitz and Akusjarvi, 1989) . Briefly, cells were washed twice with PBS and resuspended in two packed cell volumes (PCV) of Buffer A [0.25 M sucrose, 20 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM dithiothreitol (DTT), 0.5 mM spermidine, 0.15 mM spermine] and then resuspended at 1 ϫ 10 8 cells/mL in Buffer A and left at room temperature for 5 min. Lysolecithin (Sigma) was added to 400 g/mL and the cell suspension was mixed by gentle swirling. Two volumes of Buffer B (Buffer A ϩ 3% bovine serum albumin) were added and the nuclei were pelleted at 4°C at 1000 g for 30 s. The supernatant was discarded and the nuclear pellet was spun at 25,000 g for 2 min. Buffer C [20 mM HEPES, pH 7.9, 25% glycerol, 0.42 NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM phenylmethylsulfonylfluoride (PMSF)] was added to 10 9 cells/3 mL and homogenized using a 23-G needle. The suspension was stirred on ice for 30 min and then centrifuged at 25,000 g for 30 min. The supernatant was dialyzed overnight against Buffer D (20 mM HEPES, pH 7.9, 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF) with three buffer changes. The dialysate was clarified by centrifugation at 25,000 g for 20 min and snap frozen in liquid nitrogen until analysis. Alternatively, whole-cell extracts (Fig. 1B) were prepared by sonication as described previously (Colgan et al., 1998) .
Protein quantitation, Western analysis, and polyadenylation assays
Nuclear extracts were thawed on ice and protein concentration was quantitated by the method of Lowrie using the Bio-Rad Protein Assay Kit. For Western analysis of PAP in nuclear extracts, polyclonal and affinity-purified antibodies [generous gifts from Dr. James Manley (Columbia University, NY) and Dr. Walter Keller (Biozentrum, Switzerland)] were used to probe blots that contained cell extracts from Vprϩ-, VprϪ-, R80A Vpr-superinfected cells. Controls included nuclear extracts from nocodazole-treated (0.43 M) cells in which PAP becomes hyperphosphorylated and from mock-infected cells. Revelation of PAP was performed by a sensitive luminolbased chemiluminescence method at pH 10.5 (Yakunin and Hallenbeck, 1998) .
Nonspecific polyadenylation assays were performed essentially as described (Colgan et al., 1996) with a few modifications. Briefly, at 20 h p.i., nuclear extracts were prepared as above from superinfected and control cells and diluted 2ϫ in 20 mM HEPES, pH 7.9, 0.2 mM EDTA, 0.5 mM DTT, 25 mM NaCl, 10% glycerol, and 0.5 mM PMSF. This was spun for 10 min in a microcentrifuge and loaded onto an 18 ϫ 1 cm gel filtration column containing Ultragel AcA (MW, 20,000-300,000; IBF Biotechnics, France; kindly supplied by Dr. P. Hallenbeck, Université de Montré al). Fractions (250 L) were collected and the PAP elution profile (about 97 kDa) was determined empirically by Western blot analysis and with the use of prestained molecular weight markers (Bio-Rad). Peak PAP fractions from each experimental condition were kept and dialyzed against the above buffer, except 50 mM ammonium sulfate replaced NaCl. A 10-L aliquot was used directly in polyadenylation assays as described below. In some experiments, four fractions surrounding the peak fraction (peakϪ2, Ϫ1, peak, peakϩ1, ϩ2) were included in this assay.
For this assay a radiolabeled RNA substrate is used and changes in RNA length is due to PAP activity in the extract. An SV40 RNA template is used as described before (Colgan et al., 1996) and generated in a standard in vitro transcription reaction with 50 Ci of 32 P-labeled UTP (1000 Ci/mmol; ICN). Nuclear extract (10 L) was combined with polyvinyl alcohol to 2%, 1 mM MnCl 2 , 1 mM ATP, 20 mM creatine phosphate, and 25,000 cpm 32 P-SV40 RNA in a total volume of 20 L and incubated at 30°C for 60 min. The RNA products were phenol-extracted twice, followed by a chloroform extraction, ethanol precipitated using 60 g glycogen as a carrier, and resolved on a 5% denaturing polyacrylamide/8 M urea gel with 1ϫ Tris-borate-EDTA as the running buffer. Gels were directly exposed to film. PeakϪ1, Ϫ2, ϩ1, ϩ2 fractions were tested as above and reflected the PAP activities in the peak fractions as shown below (not shown).
RNA stability measurements
Jurkat cells were superinfected as described above using Vprϩ or VprϪ HIV-1 VSV-G-pseudotyped virus. At 12 h p.i., cells were treated with transcription inhibitor, Dactinomycin (Sigma; 25 M) for 12 h, followed by extensive washing (time 0). At this concentration 99% of RNA synthesis as measured by 3 H-uridine labeling is inhibited (not shown). At 0, 3, and 6, 12 h (in some experiments), cytosolic RNA was isolated and fractionated through a formaldehyde/agarose gel. The RNA was transferred to nylon membrane and probed with a 32 P-labeled DNA fragment to the HIV-1 RNA leader and glyceraldehyde dehydrogenase (GAPDH) as described before . The 28 S and 18 S rRNAs served as molecular weight markers. Autoradiographic signals were quantitated by a Molecular Dynamics phosphorimager. HIV-1 RNA levels were expressed by relating the signal obtained for each HIV-1 RNA species and related to the signal obtained for GAPDH in each lane. The signal at time 0 was set to 100%.
HIV-1 poly(A) tail length determinations
Cytosolic RNA from VprϪ, Vprϩ, and mock-superinfected cells was isolated and used in an RNAseH protocol to determine poly(A) length of HIV-1 transcripts. Total RNA (8 g) was incubated with 1.3 g antisense HIV-1 antisense oligomer [25-mer; 5Ј TGACATCGAGCT-TGCTACAAGGGAC-3Ј, targeted to nt 8953-8977 of HxBc2 (Ratner et al., 1985) , 178 nt upstream of the 3Ј polyadenylation signal of HIV-1] in 28 mM MgCl 2 , 25 mM KCl, 0.5 mM EDTA, 20 mM Tris, pH 7.5 for 5 min at 65°C and then allowed to cool to room temperature for 10 min. RNAse H (2 U) was added and incubation proceeded for an additional 45 min. This was followed by phenol:chloroform extractions and ethanol precipitation and resolution on a 2% formaldehyde/agarose gel and transfer to nylon membrane, as above. Molecular weight RNA markers were visualized by ethidium bromide staining of the gel fragment. The membrane was hybridized with a 32 Plabeled probe, generated by 5Ј-end labeling by T4 polynucleotide kinase of an 80-bp DNA that includes the TAR sequence to the HindIII site immediately downstream of the HIV-1 polyadenylation signal. In control experiments the poly(A) tail lengths of GAPDH and actin mRNAs were determined (not shown).
